Importer of Controlled Substances Application: VHG Labs DBA LGC Standard Warehouse, 58654-58657 [2017-26855]

Download as PDF 58654 Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices project remains open, and CHEDE–VII intends to file additional written notifications disclosing all changes in membership. On January 6, 2016, CHEDE–VII filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 2, 2016, (81 FR 5484). The last notification was filed with the Department on February 13, 2017. A notice was published in the Federal Register pursuant to section 6(b) of the Act on March 27, 2017, (82 FR 15239). Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [FR Doc. 2017–26890 Filed 12–12–17; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: VHG Labs DBA LGC Standard Warehouse ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 12, 2018. Such persons may also file a written request for a hearing on the application on or before January 12, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette DATES: Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix of subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on April 4, 2017, VHG LABS DBA LGC Standards Warehouse, 3 Perimeter Road, Manchester, New Hampshire 03103 applied to be registered as an importer of the following basic classes of controlled substances: sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code 3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-Fluoro-N-methylcathinone (4-FMC) .............................................................................................................................. Pentedrone (a-methylaminovalerophenone) ................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................ Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Fenethylline ..................................................................................................................................................................... 4-Methylaminorex (cis isomer) ........................................................................................................................................ Methaqualone .................................................................................................................................................................. Mecloqualone .................................................................................................................................................................. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................. 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ................. AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................... JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ....................................................................................................................... ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................. APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .............................................................. JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................... SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ...................................................................... JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................. JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................ JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ........................................................................................... AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................. 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................................. Alpha-ethyltryptamine ...................................................................................................................................................... Ibogaine ........................................................................................................................................................................... CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ........................................... VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 1590 2565 2572 6250 7008 7011 7012 7019 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 58655 Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code Lysergic acid diethylamide .............................................................................................................................................. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ................................................................................................ Marihuana ........................................................................................................................................................................ Parahexyl ......................................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ............................................................................................ 3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 2,5-Dimethoxyamphetamine ............................................................................................................................................ JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 3,4-Methylenedioxyamphetamine .................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ 4-Methoxyamphetamine .................................................................................................................................................. Peyote .............................................................................................................................................................................. 5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. Alpha-methyltryptamine ................................................................................................................................................... Bufotenine ........................................................................................................................................................................ Diethyltryptamine ............................................................................................................................................................. Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ N-Methyl-3-piperidyl benzilate ......................................................................................................................................... N-Benzylpiperazine .......................................................................................................................................................... 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ..................................................................................................... 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) .................................................................................................. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) .................................................................................................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ................................................................................................................. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ........................................................................................................ 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ................................................................................................... 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) ..................................................................................................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) .................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) ..................................................... 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) ..................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .......................................................................................................................... AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................... Acetyldihydrocodeine ....................................................................................................................................................... Benzylmorphine ............................................................................................................................................................... Codeine-N-oxide .............................................................................................................................................................. Cyprenorphine ................................................................................................................................................................. Desomorphine ................................................................................................................................................................. Etorphine (except HCl) .................................................................................................................................................... Codeine methylbromide ................................................................................................................................................... Dihydromorphine ............................................................................................................................................................. Difenoxin .......................................................................................................................................................................... Heroin .............................................................................................................................................................................. Hydromorphinol ............................................................................................................................................................... Methyldesorphine ............................................................................................................................................................ Methyldihydromorphine ................................................................................................................................................... Morphine methylbromide ................................................................................................................................................. Morphine methylsulfonate ............................................................................................................................................... Morphine-N-oxide ............................................................................................................................................................ Myrophine ........................................................................................................................................................................ Nicocodeine ..................................................................................................................................................................... Nicomorphine ................................................................................................................................................................... Normorphine .................................................................................................................................................................... Pholcodine ....................................................................................................................................................................... Thebacon ......................................................................................................................................................................... VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1 7315 7348 7360 7374 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7415 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7532 7535 7536 7537 7540 7541 7542 7545 7546 7694 9051 9052 9053 9054 9055 9056 9070 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 58656 Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code Acetorphine ...................................................................................................................................................................... Drotebanol ....................................................................................................................................................................... Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... Alphameprodine ............................................................................................................................................................... Alphamethadol ................................................................................................................................................................. Benzethidine .................................................................................................................................................................... Betacetylmethadol ........................................................................................................................................................... Betameprodine ................................................................................................................................................................ Betamethadol ................................................................................................................................................................... Betaprodine ..................................................................................................................................................................... Clonitazene ...................................................................................................................................................................... Dextromoramide .............................................................................................................................................................. Diampromide ................................................................................................................................................................... Dimenoxadol .................................................................................................................................................................... Dimepheptanol ................................................................................................................................................................. Dimethylthiambutene ....................................................................................................................................................... Dioxaphetyl butyrate ........................................................................................................................................................ Dipipanone ....................................................................................................................................................................... Ethylmethylthiambutene .................................................................................................................................................. Etonitazene ...................................................................................................................................................................... Etoxeridine ....................................................................................................................................................................... Furethidine ....................................................................................................................................................................... Ketobemidone .................................................................................................................................................................. Levomoramide ................................................................................................................................................................. Levophenacylmorphan .................................................................................................................................................... Morpheridine .................................................................................................................................................................... Noracymethadol ............................................................................................................................................................... Normethadone ................................................................................................................................................................. Norpipanone .................................................................................................................................................................... Phenadoxone ................................................................................................................................................................... Phenoperidine .................................................................................................................................................................. Piritramide ........................................................................................................................................................................ Proheptazine .................................................................................................................................................................... Properidine ...................................................................................................................................................................... Racemoramide ................................................................................................................................................................ Trimeperidine ................................................................................................................................................................... Phenomorphan ................................................................................................................................................................ Propiram .......................................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. Tilidine ............................................................................................................................................................................. Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Thiofentanyl ..................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... Phenmetrazine ................................................................................................................................................................. Amobarbital ...................................................................................................................................................................... Pentobarbital .................................................................................................................................................................... Secobarbital ..................................................................................................................................................................... Glutethimide ..................................................................................................................................................................... Nabilone ........................................................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ Phencyclidine ................................................................................................................................................................... Phenylacetone ................................................................................................................................................................. 1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ Alphaprodine .................................................................................................................................................................... Anileridine ........................................................................................................................................................................ Etorphine HCl .................................................................................................................................................................. Dihydrocodeine ................................................................................................................................................................ Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Ethylmorphine .................................................................................................................................................................. Levomethorphan .............................................................................................................................................................. Levorphanol ..................................................................................................................................................................... Isomethadone .................................................................................................................................................................. Meperidine ....................................................................................................................................................................... VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\13DEN1.SGM 13DEN1 9319 9335 9601 9602 9603 9604 9605 9606 9607 9608 9609 9611 9612 9613 9615 9617 9618 9619 9621 9622 9623 9624 9625 9626 9628 9629 9631 9632 9633 9635 9636 9637 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9812 9813 9814 9815 9830 9831 9832 9833 9835 1105 1631 2125 2270 2315 2550 7379 7460 7471 8501 8603 9010 9020 9059 9120 9170 9180 9190 9210 9220 9226 9230 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II 58657 Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Notices Controlled substance Drug code Meperidine intermediate-A .............................................................................................................................................. Meperidine intermediate-B .............................................................................................................................................. Meperidine intermediate-C .............................................................................................................................................. Metazocine ...................................................................................................................................................................... Metopon ........................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. Dihydroetorphine ............................................................................................................................................................. Levo-alphacetylmethadol ................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Phenazocine .................................................................................................................................................................... Piminodine ....................................................................................................................................................................... Racemethorphan ............................................................................................................................................................. Racemorphan .................................................................................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... Bezitramide ...................................................................................................................................................................... Moramide-intermediate .................................................................................................................................................... The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: December 7, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–26855 Filed 12–12–17; 8:45 am] BILLING CODE 4410–09–P NUCLEAR REGULATORY COMMISSION [Docket Nos. 52–025 and 52–026; NRC– 2008–0252] Southern Nuclear Operating Company, Inc., Vogtle Electric Generating Plant, Units 3 and 4; Inspections, Tests, Analyses, and Acceptance Criteria Consolidation Nuclear Regulatory Commission. ACTION: Exemption and combined license amendment; issuance. sradovich on DSK3GMQ082PROD with NOTICES AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is granting an exemption to allow a departure from elements of the certification information of Tier 1 of the generic AP1000 design control document (DCD) and is issuing License Amendment Nos. 85 and 84 to SUMMARY: VerDate Sep<11>2014 18:53 Dec 12, 2017 Jkt 244001 Combined Licenses (COL), NPF–91 and NPF–92, respectively. The COLs were issued to Southern Nuclear Operating Company, Inc. (SNC), and Georgia Power Company, Oglethorpe Power Corporation, MEAG Power SPVM, LLC, MEAG Power SPVJ, LLC, MEAG Power SPVP, LLC, Authority of Georgia, and the City of Dalton, Georgia (the licensee); for construction and operation of the Vogtle Electric Generating Plant (VEGP) Units 3 and 4, located in Burke County, Georgia. The granting of the exemption allows the changes to Tier 1 information asked for in the amendment. Because the acceptability of the exemption was determined in part by the acceptability of the amendment, the exemption and amendment are being issued concurrently. DATES: The exemption and amendment were issued on August 24, 2017. ADDRESSES: Please refer to Docket ID NRC–2008–0252 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document using any of the following methods: • Federal Rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC–2008–0252. Address questions about NRC dockets to Carol Gallagher; telephone: 301–415–3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/ PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 9232 9233 9234 9240 9260 9273 9334 9648 9668 9715 9730 9732 9733 9737 9739 9740 9743 9780 9800 9802 Schedule II II II II II II II II II II II II II II II II II II II II adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced (if it is available in ADAMS) is provided the first time that it is mentioned in this document. The request for the amendment and exemption was submitted by letter dated March 2, 2017, and supplemented by letter dated July 28, 2017, (ADAMS Accession Nos. ML17061A747 and ML17209A770, respectively) designated License Amendment Request (LAR) 17– 006. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. FOR FURTHER INFORMATION CONTACT: William (Billy) Gleaves, Office of New Reactors, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–5848; email: Bill.Gleaves@nrc.gov. SUPPLEMENTARY INFORMATION: I. Introduction The NRC is granting an exemption from paragraph B of section III, ‘‘Scope and Contents,’’ of appendix D, ‘‘Design Certification Rule for the AP1000,’’ to part 52 of title 10 of the Code of Federal Regulations (10 CFR), and issuing License Amendment Nos. 85 and 84 to COLs, NPF–91 and NPF–92, respectively, to the licensee. The exemption is required by paragraph A.4 of section VIII, ‘‘Processes for Changes and Departures,’’ appendix D, to 10 CFR E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)]
[Notices]
[Pages 58654-58657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-26855]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: VHG Labs DBA LGC 
Standard Warehouse

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 12, 2018. 
Such persons may also file a written request for a hearing on the 
application on or before January 12, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix of subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on April 
4, 2017, VHG LABS DBA LGC Standards Warehouse, 3 Perimeter Road, 
Manchester, New Hampshire 03103 applied to be registered as an importer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).......            1233  I
Cathinone................................            1235  I
Methcathinone............................            1237  I
4-Fluoro-N-methylcathinone (4-FMC).......            1238  I
Pentedrone ([alpha]-                                 1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone)..            1248  I
4-Methyl-N-ethylcathinone (4-MEC)........            1249  I
Naphyrone................................            1258  I
N-Ethylamphetamine.......................            1475  I
N,N-Dimethylamphetamine..................            1480  I
Fenethylline.............................            1503  I
4-Methylaminorex (cis isomer)............            1590  I
Methaqualone.............................            2565  I
Mecloqualone.............................            2572  I
JWH-250 (1-Pentyl-3-(2-                              6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-                      7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-              7011  I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-                  7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)..            7019  I
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-               7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
APINACA and AKB48 N-(1-Adamantyl)-1-                 7048  I
 pentyl-1H-indazole-3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4-                           7081  I
 methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1-Pentyl-3-             7104  I
 [(4-methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-Pentyl-3-           7118  I
 (1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-                     7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-             7144  I
 tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)..            7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-            7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-                     7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                              7203  I
 chlorophenylacetyl) indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-           7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                        7225  I
 fluoropentyl)-1H-indole-3-carboxylate).
Alpha-ethyltryptamine....................            7249  I
Ibogaine.................................            7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-                 7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                      7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).

[[Page 58655]]

 
Lysergic acid diethylamide...............            7315  I
2,5-Dimethoxy-4-(n)-                                 7348  I
 propylthiophenethylamine (2C-T-7).
Marihuana................................            7360  I
Parahexyl................................            7374  I
Mescaline................................            7381  I
2-(4-Ethylthio-2,5-dimethoxyphenyl)                  7385  I
 ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine..............            7390  I
4-Bromo-2,5-dimethoxyamphetamine.........            7391  I
4-Bromo-2,5-dimethoxyphenethylamine......            7392  I
4-Methyl-2,5-dimethoxyamphetamine........            7395  I
2,5-Dimethoxyamphetamine.................            7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-                     7398  I
 naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine.........            7399  I
3,4-Methylenedioxyamphetamine............            7400  I
5-Methoxy-3,4-methylenedioxyamphetamine..            7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine..            7402  I
3,4-Methylenedioxy-N-ethylamphetamine....            7404  I
3,4-Methylenedioxymethamphetamine........            7405  I
4-Methoxyamphetamine.....................            7411  I
Peyote...................................            7415  I
5-Methoxy-N-N-dimethyltryptamine.........            7431  I
Alpha-methyltryptamine...................            7432  I
Bufotenine...............................            7433  I
Diethyltryptamine........................            7434  I
Dimethyltryptamine.......................            7435  I
Psilocybin...............................            7437  I
Psilocyn.................................            7438  I
5-Methoxy-N,N-diisopropyltryptamine......            7439  I
N-Ethyl-1-phenylcyclohexylamine..........            7455  I
1-(1-Phenylcyclohexyl)pyrrolidine........            7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine....            7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine...            7473  I
N-Ethyl-3-piperidyl benzilate............            7482  I
N-Methyl-3-piperidyl benzilate...........            7484  I
N-Benzylpiperazine.......................            7493  I
4-Methyl-alphapyrrolidinopropiophenone (4-           7498  I
 MePPP).
2-(2,5-Dimethoxy-4-methylphenyl)                     7508  I
 ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl)                      7509  I
 ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)            7517  I
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine            7518  I
 (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl)                     7519  I
 ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl)                     7521  I
 ethanamine (2C-N).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl)             7532  I
 ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone)....            7535  I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-                7536  I
 methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-               7537  I
 methoxybenzyl) ethanamine (25C-NBOMe).
Methylone (3,4-Methylenedioxy-N-                     7540  I
 methylcathinone).
Butylone.................................            7541  I
Pentylone................................            7542  I
alpha-pyrrolidinopentiophenone ([alpha]-             7545  I
 PVP).
alpha-pyrrolidinobutiophenone ([alpha]-              7546  I
 PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2-                     7694  I
 iodobenzoyl) indole).
Acetyldihydrocodeine.....................            9051  I
Benzylmorphine...........................            9052  I
Codeine-N-oxide..........................            9053  I
Cyprenorphine............................            9054  I
Desomorphine.............................            9055  I
Etorphine (except HCl)...................            9056  I
Codeine methylbromide....................            9070  I
Dihydromorphine..........................            9145  I
Difenoxin................................            9168  I
Heroin...................................            9200  I
Hydromorphinol...........................            9301  I
Methyldesorphine.........................            9302  I
Methyldihydromorphine....................            9304  I
Morphine methylbromide...................            9305  I
Morphine methylsulfonate.................            9306  I
Morphine-N-oxide.........................            9307  I
Myrophine................................            9308  I
Nicocodeine..............................            9309  I
Nicomorphine.............................            9312  I
Normorphine..............................            9313  I
Pholcodine...............................            9314  I
Thebacon.................................            9315  I

[[Page 58656]]

 
Acetorphine..............................            9319  I
Drotebanol...............................            9335  I
Acetylmethadol...........................            9601  I
Allylprodine.............................            9602  I
Alphacetylmethadol except levo-                      9603  I
 alphacetylmethadol.
Alphameprodine...........................            9604  I
Alphamethadol............................            9605  I
Benzethidine.............................            9606  I
Betacetylmethadol........................            9607  I
Betameprodine............................            9608  I
Betamethadol.............................            9609  I
Betaprodine..............................            9611  I
Clonitazene..............................            9612  I
Dextromoramide...........................            9613  I
Diampromide..............................            9615  I
Dimenoxadol..............................            9617  I
Dimepheptanol............................            9618  I
Dimethylthiambutene......................            9619  I
Dioxaphetyl butyrate.....................            9621  I
Dipipanone...............................            9622  I
Ethylmethylthiambutene...................            9623  I
Etonitazene..............................            9624  I
Etoxeridine..............................            9625  I
Furethidine..............................            9626  I
Ketobemidone.............................            9628  I
Levomoramide.............................            9629  I
Levophenacylmorphan......................            9631  I
Morpheridine.............................            9632  I
Noracymethadol...........................            9633  I
Normethadone.............................            9635  I
Norpipanone..............................            9636  I
Phenadoxone..............................            9637  I
Phenoperidine............................            9641  I
Piritramide..............................            9642  I
Proheptazine.............................            9643  I
Properidine..............................            9644  I
Racemoramide.............................            9645  I
Trimeperidine............................            9646  I
Phenomorphan.............................            9647  I
Propiram.................................            9649  I
1-Methyl-4-phenyl-4-propionoxypiperidine.            9661  I
1-(2-Phenylethyl)-4-phenyl-4-                        9663  I
 acetoxypiperidine.
Tilidine.................................            9750  I
Para-Fluorofentanyl......................            9812  I
3-Methylfentanyl.........................            9813  I
Alpha-methylfentanyl.....................            9814  I
Acetyl-alpha-methylfentanyl..............            9815  I
Beta-hydroxyfentanyl.....................            9830  I
Beta-hydroxy-3-methylfentanyl............            9831  I
Alpha-methylthiofentanyl.................            9832  I
3-Methylthiofentanyl.....................            9833  I
Thiofentanyl.............................            9835  I
Methamphetamine..........................            1105  II
Phenmetrazine............................            1631  II
Amobarbital..............................            2125  II
Pentobarbital............................            2270  II
Secobarbital.............................            2315  II
Glutethimide.............................            2550  II
Nabilone.................................            7379  II
1-Phenylcyclohexylamine..................            7460  II
Phencyclidine............................            7471  II
Phenylacetone............................            8501  II
1-Piperidinocyclohexanecarbonitrile......            8603  II
Alphaprodine.............................            9010  II
Anileridine..............................            9020  II
Etorphine HCl............................            9059  II
Dihydrocodeine...........................            9120  II
Diphenoxylate............................            9170  II
Ecgonine.................................            9180  II
Ethylmorphine............................            9190  II
Levomethorphan...........................            9210  II
Levorphanol..............................            9220  II
Isomethadone.............................            9226  II
Meperidine...............................            9230  II

[[Page 58657]]

 
Meperidine intermediate-A................            9232  II
Meperidine intermediate-B................            9233  II
Meperidine intermediate-C................            9234  II
Metazocine...............................            9240  II
Metopon..................................            9260  II
Dextropropoxyphene, bulk (non-dosage                 9273  II
 forms).
Dihydroetorphine.........................            9334  II
Levo-alphacetylmethadol..................            9648  II
Noroxymorphone...........................            9668  II
Phenazocine..............................            9715  II
Piminodine...............................            9730  II
Racemethorphan...........................            9732  II
Racemorphan..............................            9733  II
Alfentanil...............................            9737  II
Remifentanil.............................            9739  II
Sufentanil...............................            9740  II
Carfentanil..............................            9743  II
Tapentadol...............................            9780  II
Bezitramide..............................            9800  II
Moramide-intermediate....................            9802  II
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytical purposes. 
Placement of these drug codes onto the company's registration does not 
translate into automatic approval of subsequent permit applications to 
import controlled substances. Approval of permit applications will 
occur only when the registrant's business activity is consistent with 
what is authorized under 21 U.S.C. 952(a)(2). Authorization will not 
extend to the import of FDA approved or non-approved finished dosage 
forms for commercial sale.

    Dated: December 7, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-26855 Filed 12-12-17; 8:45 am]
 BILLING CODE 4410-09-P